📅 2 September 2026🏷 Other Neurotoxins

How Long Does Jeuveau Last? The Label Does Not Say, and That Matters

By Lucas, Founder & Lead Researcher

Reviewed for medical accuracy against our Medical Review Board · Last updated 2 September 2026

Every page you will find on this question gives you a number, usually three to four months. We went to the source, and the honest answer is more useful than the number.

The Jeuveau label does not state how long it lasts. There is no duration of effect sentence in it. We read all six approved neurotoxin labels to check whether that is normal. It is not: two of the six do state one.

What the Jeuveau label actually contains. One efficacy timepoint, Day 30. One timing instruction, "retreatment no more frequently than every three months", which is a minimum safe interval and not a duration. And the statement that no formal pharmacodynamic studies have been conducted with it. So the "three to four months" you will read is extrapolated from practice and from other products, not quoted from this one.

What the label says, and what it does not

Jeuveau's approval rests on two trials, EV-001 and EV-002, which enrolled 654 people and measured one thing: the proportion achieving a two-grade improvement in glabellar line severity at Day 30, scored independently by both the investigator and the patient. It worked in 68% and 70% of patients against a 1% placebo rate.

Day 30 is the only efficacy timepoint in the label. The trials did not publish a fade curve, a median duration, or a proportion still responding at three or six months. So there is no labelled basis for any statement about when a Jeuveau result ends.

There is a second gap that compounds it. The label states, in its own words, that "no formal pharmacodynamic studies have been conducted with JEUVEAU". A pharmacodynamic study is what would establish onset, peak and decline. It has not been done for this product. In fairness, the Letybo label contains the identical sentence about Letybo, so this is a pattern across the newer brands rather than a Jeuveau failing.

The three-month rule is a floor, not a fade

The one timing sentence in the Jeuveau label is this: "Retreatment of JEUVEAU should be administered no more frequently than every three months." The label adds that consideration of the cumulative dose is necessary.

That sentence is routinely repurposed online as evidence that Jeuveau lasts three months. It says nothing of the kind. It is a safety limit on how often you may be injected, set to manage cumulative exposure to the toxin and the risk of developing antibodies to it. A three-month floor is compatible with a result that fades at two months and with one that holds at five.

Notice that the same instruction appears across the class. Daxxify's label says it should be administered no more frequently than every three months for any indication. Dysport's says re-treatment should not occur at intervals of less than 12 weeks. These are all floors, and none of them is a duration.

Which brands actually state a duration

We queried all six FDA labels and looked specifically in the glabellar sections, because several of these products also treat spasticity and cervical dystonia, and those sections contain duration figures that do not apply to a frown line.

Product	Duration stated in the label for glabellar lines
Botox Cosmetic	Yes. "The duration of effect of BOTOX Cosmetic for glabellar lines is approximately 3-4 months"
Dysport	Yes. "Treatment with DYSPORT reduced the severity of glabellar lines for up to four months"
Xeomin	No. Its duration references are cervical dystonia and sialorrhea dosing considerations
Daxxify	No. None anywhere in the label
Letybo	No
Jeuveau	No

So two of six. If you want a duration that a regulator has reviewed for the frown lines between your brows, those two are the only products that offer one, and both land at about four months. Our pages on how long Botox lasts and how long Dysport lasts go through those numbers, and how long Xeomin lasts covers the same gap for that product.

The Daxxify problem

This is worth its own section because Daxxify is the brand most often positioned against Jeuveau on longevity, and the comparison is not what it appears.

Daxxify's entire market position is that it lasts longer, and its label states no duration of effect at all. We checked every one of the 34 sections in it. The only references to months are the three-month minimum interval, a note that adverse reactions may persist for weeks or months, and a warning that swallowing problems may last several months.

That is not an accusation. Daxxify's trials may well support a longer result, and its manufacturer publishes data of its own. It does mean that if you are choosing between Jeuveau and Daxxify on how long each lasts, neither product's approval gives you a figure to compare. You would be comparing two marketing claims, not two labels.

So what should you expect

Here is what can be said honestly, and where each part comes from.

Something should be visible within days. Botox Cosmetic's label describes onset of muscle weakness one to two days after injection, increasing over the first week. Jeuveau has no pharmacodynamic study of its own, but the mechanism is the same across the class: the toxin cleaves SNAP-25 and the nerve terminal takes time to stop signalling.
Day 30 is when it was measured. That is the point at which 68% to 70% of patients showed a two-grade improvement, so it is a reasonable point to judge your own result.
You cannot be re-treated sooner than three months. That is a hard label instruction, not a scheduling preference.
Anything more precise than that, for Jeuveau specifically, is not in the evidence. Practitioners will tell you three to four months and they may be entirely right. It is experience, not an approved claim.

One more thing worth knowing: the effect does not switch off. Muscle activity returns gradually as the nerve terminal recovers and new nerve endings sprout, so the line reappears over weeks rather than on a particular day. That is why "how long does it last" has no single answer even for the two products whose labels do give a figure.

What to ask at your appointment

Is my area the one Jeuveau is approved for? Only the glabella is. Anything else is off-label with this product, which also means no labelled dose and no duration.
What are you basing the duration estimate on? A good answer is their own experience with this product. There is no label figure to cite.
When can I be seen again? Three months is the floor. Ask what they recommend and why.
If it fades in six weeks, what then? Worth agreeing before, not after. You cannot simply be re-injected early.
Would a product with a labelled duration suit me better? Botox Cosmetic and Dysport are the two that have one.

For the rest of what the label does and does not contain, see our full Jeuveau guide. For the two products side by side, see Botox vs Jeuveau, and for why the unit counts are not comparable across brands, the unit conversion page. The area itself is covered on frown lines and the glabella.

Frequently asked questions

How long does Jeuveau last?

The label does not say, and that is the honest answer. There is no duration of effect statement anywhere in the Jeuveau prescribing information, and the only efficacy timepoint its two trials report is Day 30. The widely quoted three to four months comes from practice and from other products, not from this approval. What the label does state is that retreatment should be no more frequent than every three months, which is a minimum safe interval rather than a duration.

Does Jeuveau last longer than Botox?

No published label supports a comparison. Botox Cosmetic states a duration of approximately three to four months for glabellar lines; Jeuveau states none. Since one has a labelled figure and the other does not, there is nothing to compare directly, and no trial has run the two against each other on duration.

Why can I only have Jeuveau every three months?

It is a safety limit on cumulative exposure, written into the label as "retreatment should be administered no more frequently than every three months", with a note that the cumulative dose has to be considered. Injecting botulinum toxin more often raises total exposure and the possibility of developing antibodies that reduce future response. The same kind of floor appears across the class: Daxxify says every three months for any indication, and Dysport says intervals of not less than 12 weeks.

Which neurotoxin has a labelled duration?

Two of the six. Botox Cosmetic states approximately three to four months for glabellar lines, and Dysport states that treatment reduced glabellar line severity for up to four months. Xeomin, Daxxify, Letybo and Jeuveau state no duration for glabellar lines. For Xeomin the duration references in its label belong to cervical dystonia and sialorrhea dosing.

Does Daxxify really last six months?

Its label does not say so. We checked all 34 sections of the Daxxify prescribing information and found no duration of effect claim at all; the only month references are the three-month minimum retreatment interval and how long adverse reactions may persist. That is not evidence against a longer result, and the manufacturer publishes its own data. It does mean that comparing Jeuveau and Daxxify on duration means comparing marketing claims rather than labels.

How soon will I see Jeuveau working?

Within days, though Jeuveau itself has no pharmacodynamic study to cite: its label states that no formal pharmacodynamic studies have been conducted. The Botox Cosmetic label, for the same class of drug, describes onset of muscle weakness one to two days after injection and increasing through the first week. Jeuveau's own trials measured results at Day 30.

Sources

Every figure on this page was read from the documents below rather than from a clinic or a manufacturer's marketing. They open in a new tab so you can check any claim here against its source.

JEUVEAU (prabotulinumtoxinA-xvfs) for injection, full prescribing information, US National Library of Medicine, DailyMed
FDA-approved botulinum toxin products, US Food and Drug Administration
Drugs@FDA approval database, US Food and Drug Administration

Written by

Lucas Pradella

Founder & Lead Researcher, BestBotoxClinics.com

Lucas founded BestBotoxClinics.com to bring clarity to the aesthetics industry, bringing 13+ years of experience in digital research and analysing online data for signals of quality and trust. He is not a physician, his work is research, data analysis and verifying provider credentials.

More about Lucas · How we work

Medical accuracy: BestBotoxClinics.com maintains a Medical Review Board of licensed clinicians. This article is educational and is not medical advice.